Albemarle (ALB) Tops Q1 EPS by 8c, Updates FY Guidance
Get Alerts ALB Hot Sheet
Financial Fact:
Interest and financing expenses: -15.95M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Albemarle (NYSE: ALB) reported Q1 EPS of $1.05, $0.08 better than the analyst estimate of $0.97. Revenue for the quarter came in at $722.1 million versus the consensus estimate of $682.55 million.
Outlook
Our strong start to 2017 in Lithium and Bromine Specialties, and continued favorable outlooks in both businesses have made us more optimistic about full year 2017. Based on this we are raising our annual guidance as follows:
Previous Outlook | Increase | Current Outlook | |||
Net sales | $2.8 - $2.95 billion | $0.1 billion | $2.9 - $3.05 billion | ||
Adjusted EBITDA | $800 - $840 million | $35 million | $835 - $875 million | ||
Adjusted EPS (per diluted share) | $4.00 - $4.25 | $0.20 | $4.20 - $4.40 |
For earnings history and earnings-related data on Albemarle (ALB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
- Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share